Susquehanna analyst Christopher Rolland lowered the firm’s price target on Texas Instruments (TXN) to $200 from $240 and keeps a Positive rating on the shares. The firm said they reported better Q3 results but worse Q4 guidance while management noted booking patterns progressed as anticipated throughout the quarter, in contrast to the moderation at the end of 2Q, an incremental positive. Susquehanna said the the long-term story remains intact as the company leans into the structural and cyclical growth story in semis.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TXN:
- Texas Instruments price target lowered to $210 from $225 at JPMorgan
- Texas Instruments price target lowered to $200 from $230 at Goldman Sachs
- Texas Instruments price target lowered to $220 from $240 at KeyBanc
- Texas Instruments Reports Strong Q3 2025 Earnings
- Long-Term Growth Potential for Texas Instruments Amid Current Challenges: A Buy Recommendation
